A case of a trans-masculine patient receiving testosterone with a history of estrogen receptor-positive breast cancer

Breast J. 2020 Sep;26(9):1888-1889. doi: 10.1111/tbj.13829. Epub 2020 Apr 7.

Authors

Erik Eckhert¹, Benjamin Laniakea², Allison W Kurian³

Affiliations

¹ Department of Medicine, Stanford University School of Medicine, Stanford, California.
² Department of Primary Care and Population Health, Stanford University School of Medicine, Stanford, California.
³ Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.

PMID: 32255524
DOI: 10.1111/tbj.13829

No abstract available

Keywords: aromatase inhibitor; breast cancer; transgender health.

Publication types

Case Reports

MeSH terms

Aromatase Inhibitors
Breast Neoplasms* / drug therapy
Female
Humans
Receptors, Estrogen*
Testosterone / adverse effects

Substances

Aromatase Inhibitors
Receptors, Estrogen
Testosterone